NNC0662-0419 is named as a drug or biological intervention in 4 clinical trials in our USA trial register, 2 of which are recruiting. The lead sponsor is Novo Nordisk A/S. Registered phases: Phase 2 and Phase 1. Conditions studied include Obesity; Overweight; Diabetes Mellitus, Type 2.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07415954 | A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes Diabetes Mellitus, Type 2 |
Phase 2 | Recruiting |
| NCT07525791 | A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight (ClinicalTrials.gov ↗) Overweight, Obesity |
Phase 1 | Recruiting |
| NCT07184632 | A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity (ClinicalTrials.gov ↗) Overweight, Obesity |
Phase 2 | Active, closed |
| NCT07639021 | A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity (ClinicalTrials.gov ↗) Obesity |
Phase 2 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Obesity | 3 |
| Overweight | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Lead sponsor | Trials |
|---|---|
| Novo Nordisk A/S | 4 |
| Register | NNC0662-0419 trials |
|---|---|
| Clinical trials in USA | 4 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how NNC0662-0419 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists NNC0662-0419 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.